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Early detectionDetection of Alzheimer's disease (AD) at the ﬁrst stages of the pathology is an important task to accelerate
the development of new therapies and improve treatment. Compared to AD detection, the prediction of AD
using structural MRI at the mild cognitive impairment (MCI) or pre-MCI stage is more complex because
the associated anatomical changes are more subtle. In this study, we analyzed the capability of a recently pro-
posed method, SNIPE (Scoring by Nonlocal Image Patch Estimator), to predict AD by analyzing entorhinal
cortex (EC) and hippocampus (HC) scoring over the entire ADNI database (834 scans). Detection (AD vs.
CN) and prediction (progressive — pMCI vs. stable — sMCI) efﬁciency of SNIPE were studied using volumetric
and grading biomarkers. First, our results indicate that grading-based biomarkers are more relevant for pre-
diction than volume-based biomarkers. Second, we show that HC-based biomarkers are more important than
EC-based biomarkers for prediction. Third, we demonstrate that the results obtained by SNIPE are similar to
or better than results obtained in an independent study using HC volume, cortical thickness, and tensor-
based morphometry, individually and in combination. Fourth, a comparison of new patch-based methods
shows that the nonlocal redundancy strategy involved in SNIPE obtained similar results to a new local
sparse-based approach. Finally, we present the ﬁrst results of patch-based morphometry to illustrate the
progression of the pathology.
© 2012 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
The diagnosis of Alzheimer's disease (AD) at pre-clinical stages or the
prediction of conversion of patients with mild cognitive impairment
(MCI) to AD is a very challenging problem receiving attention because
of the immense associated social and economic costs. Longitudinale Recherche en Informatique,
ux, France.
).
ined from the Alzheimer's Dis-
ni.ucla.edu/ADNI). Hence, the
and implementation of ADNI
ysis or writing of this report.
at www.loni.ucla.edu/ADNI/
Inc. Open access under CC BY-NC-ND lstudies have examined cognitive capacities during aging and demon-
strate that alterations with signiﬁcant decline occur more than a decade
prior to clinical diagnosis (Amieva et al., 2008; Elias et al., 2000). Re-
search fromdiverse scientiﬁc disciplines has focused increasing attention
on identifying the earliest prodromal signs and risk factors for
Alzheimer's disease (Ballard et al., 2011).
Several biomarker candidates have already been studied in depth
with the goal of achieving this task. For example, the presence of
amyloid-β (Aβ), a hallmark of AD, seems to occur in the very early course
of the pathology, long before the typical clinical, behavioral, and social
criteria of dementia are fully met (Frisoni et al., 2010). Aβ presence can
be studied using cerebrospinal ﬂuid (CSF) markers or positron emission
tomography (PET). Generally speaking, the results found are heteroge-
neous, and therefore, links between Aβ burden and cognitive deﬁcits
are still unknown (Aizenstein et al., 2008; Chetelat et al., 2010;
Kantarci et al., 2012; Villemagne et al., 2011). By contrast, biomarkers
based on anatomicalmagnetic resonance imaging (MRI) are increasingly
under investigation because they are considered more sensitive toicense.
Table 1
Demographic details of the dataset used.
Population size % Male Age±SD MMSE±SD
CN 231 52% 76.0±5.0 29.1±0.9
sMCI 238 67% 74.9±7.7 27.2±2.5
pMCI 167 60% 74.5±7.2 26.4±2.0
AD 198 50% 75.6±7.7 22.8±2.9
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2010). Usually, these imaging biomarkers are used to detect abnormal
patterns of atrophy caused by AD on key structures in the brain; such
patterns are considered themacroscopic signs ofmicroscopic alterations.
The structures in the medial temporal lobe (MTL) are being studied
especially intensively because of their strong involvement in the patho-
genesis of AD (Braak and Braak, 1991). Recent MRI studies have also
contributed to understanding the structural changes underlying AD cog-
nitive impairment by demonstrating the association of cognitive difﬁcul-
ties with reductions in hippocampal volume (de Jong et al., 2008).
Accordingly, the histopathological investigation of Braak and Braak
(Braak and Braak, 1991) suggests that AD begins with the formation of
neuroﬁbrillary tangles in the MTL, particularly the entorhinal cortex
(EC), a structure of the parahippocampal cortex, which then continues
in the hippocampus (HC) and from there expands to other structures
throughout the neocortex. Therefore, using EC and HC atrophy as early
imaging biomarkers is considered a promising way of following the pro-
gression of AD (Frisoni et al., 2010), especially since changes in these
structures are closely related to modiﬁcations in the subject's cognitive
performance. However, the automatic extraction of theseMTL structures
is challenging, especially in the case of the EC (Du et al., 2001).Moreover,
the intersubject variability of brain anatomy tends to limit AD detection
methods that use only volumetric approaches (Coupe et al., 2012a;Wolz
et al., 2011b). These two aspects limit the capability of volume-based
imaging biomarkers that use MTL structures to characterize the earliest
stages of AD as well as to develop efﬁcacious strategies for prevention
or early intervention.
Recently, we proposed new methods to address these issues: We
developed a robust approach to automatically segment the HC and EC
(Coupe et al., 2011) and introduced a new scoringmethod to enable bet-
ter characterization of structure atrophy (Coupe et al., 2012a). In the lat-
ter work, scoring of the structure under consideration is achieved by
estimating the nonlocal similarity of the subject to different training
populations. Because it uses a nonlocal framework, our Scoring by
Nonlocal Image Patch Estimator (SNIPE) addresses the problem of
intersubject variability nicely by enabling a one-to-many mapping
between the subject's anatomy and those of the training templates.
Moreover, by employing the patch-based comparison principle, SNIPE
detects subtle changes caused by the disease, as already shown in
Coupe et al. (2012a). In this previous study, we demonstrated the high
success rate of SNIPE at detecting AD (i.e., ADpatients vs. cognitively nor-
mal (CN) individuals) in a subset of the Alzheimer's Disease Neuroimag-
ing Initiative (ADNI) database (i.e., 100 subjects).
From a clinical perspective, the ability to predict AD (i.e., identifying
progressive (pMCI) vs. stable MCI (sMCI)) is more crucial than being
able to detect AD. However, prediction is clearly more challenging
because (i) the anatomical changes to be identiﬁed are more subtle at
the prodromal phase of the disease and (ii) the heterogeneous MCI
group includes a mix of individuals, some who will convert to AD and
others who will not. The distinction between the two is the crucial test
for any proposed biomarker. Recently, several studies have compared
the sensitivity and accuracy to differentiate between sMCI and pMCI of
a number of structural imaging biomarkers such as HC volume, cortical
thickness measurements (CTH), voxel-based methods using VBM fea-
tures, and tensor-based methods using TBM features (Cho et al., 2012;
Chupin et al., 2009; Cuingnet et al., 2011; Davatzikos et al., 2011;
Koikkalainen et al., 2011; Misra et al., 2009; Querbes et al., 2009;
Westman et al., 2011; Wolz et al., 2011b). In voxel-based methods, fea-
tures similar to those involved in voxel-based morphometry (Ashburner
and Friston, 2000) (i.e., the focal tissue probabilities) are used to achieve
an individual patient's classiﬁcation, sometimes after a step of dimension-
ality reduction of the features (Kloppel et al., 2008; Vemuri et al., 2008).
Similarly, individual classiﬁcation can be also obtained using tensor-
based morphometry features (Wolz et al., 2011b). Detailed reviews and
comparisons of these imaging biomarkers can be found in Cuingnet et
al. (2011) and Wolz et al. (2011b). According to these analyses, theaccuracy of AD prediction of the usual methods (e.g., HC volume, CTH,
VBM, or TBM) is less than 66% (Wolz et al., 2011b) when applied to the
ADNI database. To the best of our knowledge, the highest prediction accu-
racy obtained on all the baseline scans of the ADNI database (834 sub-
jects) was achieved by combining the four methods, resulting in an
accuracy of 68% for pMCI versus sMCI (Wolz et al., 2011b).
In the current study, we investigate the capability of SNIPE to early
detect AD using the entire ADNI database. We compare the obtained
results with those of the different methods compared in Wolz et al.
(2011b) by using the same cohorts and the same validation framework.
Our analysis also includes results from a new sparse-based approach
proposed in Liu et al. (2012). Finally, a presentation of the pathology pro-
gression around the HC and EC is presented through a patch-basedmor-
phometry (PBM) analysis, as recently suggested in Coupe et al. (2012b).
2. Materials and methods
Data used in the preparation of this article were obtained from the
ADNI database (adni.loni.ucla.edu). The ADNI was launched in 2003
by the National Institute on Aging (NIA), the National Institute of Bio-
medical Imaging and Bioengineering (NIBIB), the Food and Drug
Administration (FDA), private pharmaceutical companies, and non-
proﬁt organizations as a $60 million, 5-year public–private partner-
ship. The primary goal of the ADNI has been to test whether serial
MRI, PET, other biological markers, and clinical and neuropsychologi-
cal assessment can be combined to measure the progression of MCI
and early AD. Determination of sensitive and speciﬁc markers of
very early AD progression is intended to aid researchers and clinicians
in developing new treatments and monitoring their effectiveness, as
well as lessen the time and cost of clinical trials.
2.1. MRI dataset
2.1.1. ADNI dataset: 834 baseline scans
The current study aims to investigate the capability of SNIPE to pro-
duce early diagnosis of AD compared with recently proposed methods.
In our experiment, the 834 baseline scans at 1.5 T of the ADNI database
were used. The scans were divided into four populations, with an MCI
subject considered progressive if he or she converted to AD as of July
2011. This population construction resulted in the four groups compos-
ing our dataset: 231 CN, 238 sMCI, 167 pMCI, and 198 AD. The four
constructed cohorts are the same as those used in Wolz et al. (2011b),
and the CN, AD, and pMCI cohorts are also the same cohorts as used in
a recently published study that used the sparse-based method (Liu et
al., 2012). Demographic details of the dataset can be found in Table 1.
2.1.2. Preprocessing
Before applying SNIPE, all the images were preprocessed through a
fully automatic pipeline, which comprised the following steps: estima-
tion of the standard deviation (SD) of Rician noise with (Coupe et al.,
2010); denoising based on an optimized nonlocal means ﬁlter (Coupe
et al., 2008); correction of inhomogeneities using N3 (Sled et al.,
1998); registration to the stereotaxic space based on a linear transform
to the ICBM152 template (1×1×1mm3 voxel size) (Collins et al., 1994)
using a population-speciﬁc template derived from the ADNI database
and constructed using the algorithm published in Fonov et al. (2011);
linear intensity normalization of each subject on template intensity;
Fig. 1. Example of SNIPE workﬂow for an MCI subject. Once the label propagation step is ﬁnished, the resulting training libraries can be used by SNIPE to estimate the grading maps
of the entire ADNI database (AD, pMCI, sMCI, and CN). In this study, SNIPE was applied following the procedure described in Coupe et al. (2012a, 2012b) (see Fig. 1).
1. Template preselection: Preselection of the N/2 closest subjects from each training library (AD and CN populations) is achieved using the sum of the squared difference over the
initialization mask.
2. Scoring of the subject under study: For each voxel (included in the initialization mask) of the subject under study (pMCI in this example), we compared the surrounding patch
with all the patches from the N training templates selected from the AD and CN populations.
3. Feature extraction: The average grading value over the HC and EC segmentations is used as the relevant feature for the classiﬁcation step.
4. Classiﬁcation: The ﬁnal classiﬁcation step is based on linear discriminant analysis using all the other subjects (AD and CN populations for AD or CN subjects, and pMCI and sMCI
populations for MCI subjects).
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the structures of interest (see Fig. 1); and cross-normalization of the
MRI intensity between the subjects using the method proposed in
Nyul and Udupa (2000) within the estimated brain mask.
2.2. Scoring by Nonlocal Image Patch Estimator (SNIPE)
Inspired by ourwork based on a nonlocal patch-based framework for
MRI denoising (Coupe et al., 2008) and for MRI segmentation (Coupe et
al., 2011), we recently proposed a new method to estimate structure
grading called SNIPE (Coupe et al., 2012a). The grading or scoring of
the structure under consideration is achieved by estimating the nonlocal
similarity of the subject under study to different training populations
(see Fig. 1). With the nonlocal framework, SNIPE is able to handle
intersubject variability by enabling a one-to-many mapping between
the subject's anatomy and those of the training templates. Moreover,
by employing the patch-based comparison principle, SNIPE can detect
subtle anatomical changes caused by the disease (see (Coupe et al.,
2012a) for details).
2.2.1. Label propagation
The ﬁrst step of the SNIPE method is to propagate a small number of
manual segmentations over the entire training library. In this study, theAD and CN populations were used as the training library to achieve
the scoring of the AD, CN, sMCI, and pMCI populations; therefore, label
propagation was performed only on AD and CN subjects. As done in
Coupe et al. (2012a), 20 scans were ﬁrst randomly selected from the
AD and CN populations (10 CN and 10 AD) for manual labeling. The
HC and EC in these 20 scans were manually segmented by an expert
using the protocol described in Pruessner et al. (2002). Then, the
manual segmentations were used to segment the entire AD and CN
populations, ensuring that no subject was used for its own segmen-
tation. Finally, automatic segmentations were available for the 231
CN subjects and 198 AD patients constituting our training library
(see Fig. 1).
2.2.2. Structure grading
Once the label propagation step was ﬁnished, the resulting training
library could be used by SNIPE to estimate the grading maps for the
entire ADNI database (AD, pMCI, sMCI, and CN). SNIPE was applied
according to the following procedure (see Fig. 1):
1) Template selection: The selection of the N/2 closest subjects from
each training population (i.e., AD and CN) is achieved using the
sum of the squared difference (SSD) over an initialization mask. For
the AD and CN subjects, we removed the subject under study from
the training library.
Fig. 2. Comparison of cross-validation (CV) procedure for AD vs. CN using hippocampal
volumes and subjects' ages in terms of success rate. The 50% vs. 50% CV, 100×
leave-N-out CV, 10-fold CV, and leave-one-out CV were compared using LDA over
1000 realizations. The mean success rates were 78.7%, 78.9%, 79.0%, and 79.1% respec-
tively. The median success rates were 78.9%, 78.9%, 78.9%, and 79.1% respectively.
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initializationmask) of the subject under study (pMCI in the example
provided in Fig. 1), we compared the surrounding patch with all the
patches from the N training templates selected from the AD and CN
populations. Thus, we simultaneously obtained a grading map and
a segmentation for the HC and EC.
3) Feature extraction: The segmentations were used to compute the
structure volumes, and the average grading value was estimated
over the HC and EC segmentations. Both biomarkers were used as
features in the classiﬁcation step.
2.2.3. Classiﬁcation
The classiﬁcation step is based on linear discriminant analysis (LDA).
In Coupe et al. (2012a), we showed that slightly better classiﬁcation
accuracy could be obtained for AD vs. CN using quadratic discriminant
analysis (QDA); however, to enable comparison with recently published
results based on linear classiﬁcation techniques (Cuingnet et al., 2011;
Wolz et al., 2011b), we used LDA in this study. Moreover, in Coupe et
al. (2012a), we demonstrated that better classiﬁcation accuracy could
be achieved by using subject age as a feature in addition to volume or
grade. Therefore, all the presented results for grade and volume
biomarkers were obtained using the ages of the subjects as an additional
feature in LDA. The correlation between the imaging biomarkers used
and subject age will be also studied here.
2.3. Validation framework design
In our validation, we tried to minimize the impact of bias during
feature extraction and feature classiﬁcation. The design of this type
of validation is challenging because of both the many possible sources
of bias and the trade-off between bias and variance.
2.3.1. Feature extraction
Theﬁrst source of biasmay occurwhen a sample is involved in its own
classiﬁcation. This type of bias, known as “double-dipping” (Kriegeskorte
et al., 2009), is sometimes difﬁcult to avoid. With methods requiring the
extraction of regions of interest (ROIs) where the populations differ the
most (e.g., VBM, TBM, CTH), this type of bias occurs often and plays a
role in recent studies carried out on the ADNI database (Koikkalainen
et al., 2011; Querbes et al., 2009;Wolz et al., 2011b).We recently showed
that double-dipping leads to a signiﬁcantly overestimated detection and
prediction accuracy (Eskildsen et al., in press).
To avoid the double-dipping bias, authors usually use strategies
based on splitting populations into training and testing folds. For
instance, in Cuingnet et al. (2011), the studied dataset is separated into
two subsets of similar sizes for VBM and CTH approaches. This technique
allowed ROIs to be estimated on the training dataset and applied to the
test dataset. However, as we will show later and as discussed in Wolz
et al. (2011b), this type of removal of the double-dipping bias in feature
extraction occurs at the expense of a drastic increase in variability of the
estimated success rates during feature classiﬁcation.
In our study, we avoid this type of bias during ROI estimation since
our ROIs are obtained by structure segmentation at the same time as
grading estimation. In our validation framework, the template selection
is achieved by removing the current subject from the library. For a
given subject, the N closest training templates were selected from all
the remaining subjects in the training library. Then, the segmentation
and grading were obtained using these N selected training templates.
This technique ensures that a given subject is not included in the training
library used by SNIPE for its own processing. The absence of double-
dipping is implicit for MCI subjects since we used the AD and CN
populations as training templates.
2.3.2. Classiﬁcation
Once all the subjects were processed using SNIPE, the ﬁnal step
consisted in subject classiﬁcation based on the extracted features,namely, volumes and grades. At this point, different possibilities were
available to perform the cross-validation (CV), several of which have
been recently used on the ADNI database.
- Controlled 50% vs. 50%: In Cuingnet et al. (2011), the authors used
the 50% vs. 50% procedure, randomly splitting each population
into two subsets (one training and one testing) with similar prop-
erties for age and gender attributes. This method should ensure
the absence of bias during classiﬁcation, but as discussed in Wolz
et al. (2011b) and later in this paper, this validation procedure
results in high variance of the distribution of success rates
according to the random population splitting.
- Repeated LNOCV: To moderate the high variance of the obtained
success rates, Wolz et al. (2011b) proposed to use a repeated
leave-N-out cross-validation (LNOCV) method. They used 95% of
the datasets as the training set and the remaining 5% as the testing
set (randomly selected). To reduce the variance of the results, they
repeated this procedure 100 times and used the mean classiﬁcation
rate as the ﬁnal result. This method requires 100×20 classiﬁcations.
- Stratiﬁed k-fold: More recently, Liu et al. (2012) proposed to use a
stratiﬁed 10-fold CV procedure. The dataset is ﬁrst split into 10 sub-
sets of similar sizes, while preserving the label proportion of the
original dataset. Then, in turn, each fold is used as the test set, and
the nine remaining folds, as the training set.
- LOOCV: In Coupe et al. (2012a), we used a leave-one-out cross-
validation (LOOCV) procedure. In this type of CV, the classiﬁer is
trained on n−1 samples and then used to classify the remaining
samples. This type of approach can be computationally expensive
depending on n, the number of subjects in the dataset.
To evaluatewhichmethod is best suited toperform theCVof theADNI
dataset, we compared the previously described approaches. Fig. 2 shows
the comparison of CV procedures for AD vs. CN using HC volumes in
terms of success rate; controlled 50% vs. 50%, 100× LNOCV, stratiﬁed
10-fold, and LOOCV were compared using an LDA classiﬁer over 1,000
realizations. The mean success rates were 78.7%, 78.9%, 79.0%, and 79.1%
respectively, and the median success rates were 78.9%, 78.9%, 78.9%, and
79.1% respectively. Although both the mean and median success rate
values were 79% for all compared validation procedures (for LOOCV,
there is only one deterministic value), high variations were observed for
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values of 84% and 82% respectively. This high variation in success rates
makes it difﬁcult to compare methods because the published results
may be derived from the median or from the extreme limits of the distri-
bution. Interestingly, the value provided by LOOCV is similar to themedi-
an values of the distribution obtained with other validation procedures.
In practice, alternative validation procedures are used in place of
LOOCV for computational reasons when a large number of samples are
involved. In the case of the ADNI dataset, the LOOCV required less than
2 seconds and was faster than the 100× LNOCV. Moreover, LOOCV is
known to be an almost unbiased estimator (Cawley and Talbot, 2004).
Therefore, we decided to use LOOCV in our validation, since the value
obtained with LOOCV corresponds to the median value of the distribu-
tions obtainedwith other CVprocedures,without any possible variations
in published results according to the random sampling. The maximum
values obtained by using 100× LNOCV and 10-fold CV are presented
only for the comparison with previously published work in order to
provide the median (i.e., LOOCV) and the upper limit of the success
rate distributions for a fairer comparison.
2.4. Implementation details
In this study, we used all the parameters proposed in Coupe et al.
(2012a), except for the patch size for EC and the number of training tem-
plates used, N. Recently, we showed in Hu et al. (in press) that a patch of
5×5×5 voxels is sufﬁcient for EC segmentation and is thus used for com-
putational reasons. Here, we used this patch size for EC and patches of
7×7×7 voxels for HC, as suggested in Coupe et al. (2012a) and Coupe
et al. (2011). In Coupe et al. (2012a), we also suggested that 60% of the
entire library be selected during template selection (i.e., 30 AD and 30
CNon the 50 available). In this study,we used only around25% of the en-
tire library (NAD=50 and NCN=50) for computational reasons. Details
on all other parameters can be found in Coupe et al. (2012a)).
3. Results
3.1. SNIPE volumetric study
Fig. 3 shows the volumes obtained by SNIPE for HC and EC. Volumes
are plotted according to subject age for the four studied populations, and
the distributions are presented as boxplots. We can observe a reduction
in the volumes with age for HC, whereas for EC, this reduction is not sta-
tistically signiﬁcant as assessed by p-values and Pearson's coefﬁcients.
For HC, a greater reduction can be noted for the AD population, a ﬁnding
that can be explained by the addition of age-related atrophy to that relat-
ed to the pathology. Themeans of theHC volume distributions are signif-
icantly different according to a multi-comparison test, and the expected
order is observed (ADbpMCIbsMCIbCN). The change in evolution of EC
volumes with age is more difﬁcult to interpret. The low Pearson's coefﬁ-
cient r and the high p-values of the linear regressions indicate a nonsig-
niﬁcant linear correlation between EC volumes and age, except for in the
AD population. Compared with the results for the HC volumes, this ﬁnd-
ing might be due to higher intersubject variability and more frequent
errors in the segmentation, as discussed in Coupe et al. (2012a). For EC
then, the pathology-related patterns seem partially obscured by the
intersubject variability. However, except for AD vs. pMCI, the means of
EC volume distributions are signiﬁcantly different according to a multi-
comparison test at 95% conﬁdence. Finally, a larger mean difference is
observed between sMCI and CN volume distributions than between AD
and pMCI (especially for EC volumes).
3.2. SNIPE grading study
Fig. 4 presents the average grading values obtained by SNIPE for HC
and EC. For the studied structures, the grading values are signiﬁcantly
correlated with age (all p-values areb0.05) and decrease with age.Moreover, this correlation holds when controlling forMMSE. In compar-
ison with those obtained in the volumetric study, the correlation coefﬁ-
cients obtained for grading are higher. As expected, CN subjects have
the highest grading values, and AD patients, the lowest. Interestingly,
the same observation holds for sMCI compared with pMCI. In all the
studied cases, the means of the grading distributions of the studied
populations were signiﬁcantly different. The HC-grade distributions
present lower variances and smaller overlap between populations
compared with EC-grade distributions. In addition, the boxplots of
grade distributions also show fewer outliers (red cross) and a smaller
overlap between distributions compared with volume distributions. Fi-
nally, as we show later in the classiﬁcation experiment by comparing
volume and grade biomarkers, the higher correlation with age enables
a better distinction between anatomical differences due to age-related
modiﬁcations and those due to pathology-related alterations, and the
lower intrapopulation variance enables a better distinction between
anatomical differences due to intersubject variability and those due to
pathology-related alterations.
Visual assessment of the changes in the grading maps with age
between populations is proposed in Fig. 5. The estimated scoring is visu-
ally lower for AD than for CN. This tendency can also be observed
between sMCI and pMCI populations, and a global decrease in grading
values with age is visible for the four studied populations. The increased
atrophy ofHC in the oldest subjects is also visible, especially for pMCI and
AD subjects aged 80 to 90 years, inwhom the combinationof age-related
and pathology-related atrophy yields signiﬁcant HC reduction.
3.3. Comparison of SNIPE-based biomarkers
Table 2 presents the classiﬁcation success rates obtained by the im-
aging biomarkers under consideration for AD vs. CN, pMCI vs. CN, AD
vs. sMCI, and pMCI vs. sMCI. These results show that (i) grading-based
biomarkers outperform volume-based biomarkers (+5% to +13%) and
(ii) EC-based biomarkers are less efﬁcient than HC-based biomarkers,
except for AD vs. sMCI where both structures provided similar accuracy.
Finally, the combination of volume and grade did not really change
results from those obtained with the use of grade only. As assessed by
p-values of McNemar test (McNemar, 1947) in Table 2, all the
SNIPE-based biomarkers performed signiﬁcantly better (i.e., pb0.05)
than random classiﬁcation for all the population comparisons consid-
ered. In addition, in order to estimate if the difference between the clas-
siﬁcation accuracy of biomarkers was signiﬁcant, we compared the
classiﬁcation results of HC and EC, and of grading and structure volumes
in Table 3. By using a conﬁdence interval at 95%, all the biomarkers have
signiﬁcantly different accuracy, except HC-grade>EC-grade for AD vs.
sMCI and pMCI vs. sMCI, and HC-vol>EC-vol for pMCI vs. sMCI.
As expected, classiﬁcation accuracies decrease when populations
with closer pathological status were used (c.f., Table 2). Thus, the lowest
accuracy was obtained for the pMCI vs. sMCI comparison. Although we
expected similar results for pMCI vs. CN and AD vs. sMCI, we found an
important difference in the classiﬁcation accuracies of these two
comparisons. With SNIPE, a clear difference between the pMCI and CN
populations was detected, whereas a less distinctive one was found for
AD and sMCI. These classiﬁcation results seem to show that (i) the
pMCI population is relatively similar to the AD population, indicating
that the pMCI population studied was advanced in pathology progres-
sion and close to conversion, and (ii) the important difference between
CN and sMCI may result from anatomical modiﬁcations of the HC and
EC in these two groups that may be related to the cognitive impairment.
Alternatively, it could point to heterogeneity in the sMCI group where
some subjects might still convert to pMCI and AD, but not have yet to
do so. These subjects may share morphological characteristics with the
pMCI group. To investigate these two possibilities further, we analyzed
the classiﬁcation results for AD vs. pMCI and sMCI vs. CN. As shown in
Table 4, the detected difference for sMCI vs. CN is clearly greater than
that for AD vs. pMCI: the classiﬁcation of AD vs. pMCI using structure
Fig. 3. SNIPE-based volumetric study. Left: Volume of HC and EC structures for studied populations according to subject age. Linear regressions are displayed for better visualization
of global tendencies. Pearson's coefﬁcients and p-values of the regressions are provided in the legend. Right: Boxplots of the distributions. Colored stars above the boxplots indicate
a signiﬁcantly different mean from those of other groups, obtained using a multi-comparison test at 95% conﬁdence.
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tion since all p-value are greater than 0.05 while for sMCI vs. CN we
obtained a signiﬁcant difference for these biomarkers.
For AD vs. CN, our results are in line with the study presented in
Coupe et al. (2012a) on 100 baseline scans using QDA, although they
were slightly lower for HC and better for EC. The improvement in EC
grading might be due to the larger training library used here, which en-
ables a better representation of EC intersubject variability. For AD vs.
sMCI, the efﬁciency of HC grading classiﬁcation accuracy drops to the
level of EC grading (as assessed by p-value in Table 3) and is closer to
the accuracy observed for the pMCI vs. sMCI comparison than that for
the pMCI vs. CN comparison. For the AD vs. sMCI comparison, HC grade
and EC grade seem to be key biomarkers to differentiate between AD
and sMCI,whereas for the other population comparisons, HC grade is sig-
niﬁcantlymore efﬁcient (see Table 3). This observation is also conﬁrmedby the results obtained for ADvs. pMCI (see Table 4)where EC grade pro-
vided better results thanHC grade. This ﬁndingmay be related to the fact
that atrophy of the EC seems to be speciﬁc to the pathological processes
associated with AD and pMCI, while a linear decrease of HC volumewith
age has been observed in healthy populations for men starting in the
third decade of life, and for women, after menopause (Pruessner et al.,
2001). Therefore, for AD vs. sMCI, the advantage of using HC-EC complex
grading compared with HC grading is the greatest (+4% while around
±1% for other comparisons, see Table 2). As shown in Coupe et al.
(2012a), for AD vs. CN, the combination of HC and EC grade tends to
slightly improve classiﬁcation accuracy. In this study, however, such
was not the case for pMCI vs. sMCI. This result was unexpected given
that the EC is believed to be affected before the HC in the evolution of
the pathology (Frisoni et al., 2010) and thus should bemore useful for di-
agnosis at the early stages of the disease. As previously pointed out, the
Fig. 4. SNIPE-based grading study. Left: Grade of HC and EC structures for studied populations according to subject age. Linear regressions are displayed for better visualization of
global tendencies. Pearson's coefﬁcients and p-values of the regressions are provided in the legend. Right: Boxplots of the distributions. Colored stars above the boxplots indicate a
signiﬁcantly different mean from those for other groups, obtained using a multi-comparison test at 95% conﬁdence.
147P. Coupé et al. / NeuroImage: Clinical 1 (2012) 141–152difﬁculties related to EC classiﬁcation (high intersubject variability in
shape and size of EC) seem to adversely affect the usefulness of this bio-
marker for early detection of AD-related pathology.
3.4. Comparison with previous work
Recently, several studies provided extensive comparisons of well-
known methods such as methods based on VBM features, methods
based on TBM features, CTH, and HC volume applied to the ADNI data-
base (Cuingnet et al., 2011; Wolz et al., 2011b). As a result, estimations
of the classiﬁcation accuracy of different imaging biomarkers can be
compared on the same large database. To the best of our knowledge,
the study proposed by Wolz et al. (2011b) is currently the mostcomprehensive work performed on the ADNI database: they used all
834 baseline scans in the ADNI database, studied different scenarios
(AD vs. CN, pMCI vs. CN and pMCI vs. sMCI), and they also showed that
their method obtained better results than all the methods compared by
Cuingnet et al. (2011) (i.e., HC volume, VBM, CTH, and HC shape) on a
smaller dataset. Therefore, we chose to compare SNIPE with the results
presented inWolz et al. (2011b) since they represent the best published
results for pMCI vs. sMCI, the differentiation of which is the main chal-
lenge from a clinical perspective.
We also compared SNIPE with very recent work on sparse
representation-based classiﬁers (SRC) applied to gray matter
(GM) and validated in the same AD, pMCI and CN populations (Liu
et al., 2012). This SRC approach and SNIPE are based on similar
Fig. 5. Typical grading maps for each population according to subject age.
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ties using patch comparisons between populations. However, sev-
eral differences can be pointed out.
- First, SNIPE uses nonlocal redundancy of information,whereas (Liu et
al., 2012) uses local sparsity. The nonlocal/local aspect impacts the
anatomy matching of subjects, which in Liu et al. (2012) is achieved
by one-to-one mapping after nonlinear registration, whereas SNIPE
performs one-to-manymappings after linear registration. The redun-
dancy/sparsity aspect differs in how patches are compared. With
redundancy, we try to use the largest possible number of patches to
take advantage of the repetition of useful information, thus making
a decision based on asmuch input as possible andminimizing poten-
tial errors. By contrast, sparsity aims to ﬁnd the smallest subset of the
most relevant patches.
- Second, SNIPE focuses on key structures such as the HC and EC, while
(Liu et al., 2012) compared the entire GM area. In Liu et al. (2012), a
preselection of the ROIs within GM areas is achieved by extracting
the most signiﬁcantly different areas between populations, similarly
to what is classically done for CTH.
Tables 5 and 6 show the results of the method comparison between
SNIPE using CV procedures proposed in the other two studies.
For AD vs. CN, the results obtained with SNIPE were similar to those
from the combination of four methods reported inWolz et al. (2011b)
(91% compared to 89% using 100× LNOCV, see Table 5). SNIPE
obtained better results than HC volume (Lotjonen et al., 2011),
manifold-based learning (Wolz et al., 2011a), CTH (Lerch and Evans,
2005), and method based on TBM features (Koikkalainen et al.,
2011), although the results from multi-template TBM and SNIPE
were close, as were those from SNIPE and patch-based SRC (Liu
et al., 2012) (90% compared to 91% using k-fold CV, see Table 6).
The results obtained for HC volumes using patch-based segmentation
(Coupe et al., 2011) and multi-template nonlinear warping (Lotjonen
et al., 2011) were also close (83% compared to 81% using 100×
LNOCV, see Table 5). These ﬁndings seem to indicate that the comparedapproaches provide similar segmentation accuracies. Interestingly, HC
grade provided results that were similar to or better than those from
methods analyzing the entire brain anatomy (i.e., method based on
TBM features, global SVM/SRC, and advanced method based on VBM
features such as COMPARE (Fan et al., 2007)) and requiring nonlinear
registration of all subjects.
For pMCI vs. CN, the results obtained by SNIPE were similar to
those from patch-based SRC (87% compared to 88% using k-fold CV,
see Table 6) but better than those from all the methods compared
in Wolz et al. (2011b) as well as their combination (88% compared
to 84% using 100× LNOCV, see Table 5). This ﬁnding seems to indicate
that new patch-based frameworks perform better than classical
methods such as HC volume or methods based on TBM features. In
addition, preselecting the most relevant GM areas or using segmenta-
tion of key structures seems to lead to similar classiﬁcation accuracy.
The latter has the advantage of directly avoiding double-dipping.
For pMCI vs. sMCI, the results obtained by SNIPE were better than
those from all the methods compared in Wolz et al. (2011b) (74%
compared to 68% using 100× LNOCV, see Table 5). This outcome high-
lights the potential of SNIPE for AD prediction by enabling the detec-
tion of subtle anatomical changes caused by AD at the early stages of
the pathology. Unfortunately, Liu et al. (2012) did not provide results
for this comparison, and thus no comparison between efﬁciency of
redundancy and sparsity can be done for early detection.
3.5. Patch-based morphometry analysis
Another important aspect of a method is its potential to visualize
the differences between populations in a compact way. This capabili-
ty is one explanation for the great success of the VBM, CTH, and TBM
methods. In their discussion, Liu et al. (2012) warn that the main
limitation of their method is the impossibility of visualizing the spa-
tial location of the most discriminant areas between populations.
They conclude that this limitation results in less clinical insight and
thus a lower understanding of the pathology mechanisms.
Table 5
Comparison of classiﬁcation results between SNIPE and methods studied in Wolz et al.
(2011b). Results shown are the best results obtained using 100× LNOCV. The
presented results are the classiﬁcation accuracy (acc) in %, the sensitivity (sen) in %
and the speciﬁcity (spe) in %. Best result for each comparison is in bold and underline.
Table 2
Classiﬁcation results obtained with different biomarkers for AD vs. CN, pMCI vs. CN,
and pMCI vs. sMCI. Results were obtained using linear discriminant analysis through
a leave-one-out cross-validation procedure. The values presented in the table corre-
spond to the classiﬁcation accuracy (acc) in %, the sensitivity (sen) in %, the speciﬁcity
(spe) in % and the p-value of the McNemar test to assess the performance of classiﬁca-
tion compared to random classiﬁcation. For each comparison (e.g., pMCI vs. CN), the
best result is in bold and underline.









Volume 79 / 76 / 82
(pb0.0001)
70 / 68 / 72
(pb0.0001)
78 / 76 / 80
(pb0.0001)
Grade 88 / 83 / 92
(pb0.0001)
83 / 75 / 90
(pb0.0001)
89 / 84 / 93
(pb0.0001)
Volume+Grade 87 / 83 / 91
(pb0.0001)
83 / 74 / 91
(pb0.0001)
88 / 84 / 92
(pb0.0001)
pMCI vs. CN HC EC HC-EC
Volume 75 / 73 / 76
(pb0.0001)
69 / 66 / 71
(pb0.0001)
75 / 74 / 75
(pb0.0001)
Grade 85 / 80 / 88
(pb0.0001)
79 / 73 / 83
(pb0.0001)
86 / 80 / 89
(pb0.0001)
Volume+Grade 85 / 80 / 88
(pb0.0001)
80 / 73 / 85
(pb0.0001)
85 / 80 / 88
(pb0.0001)
AD vs. sMCI HC EC HC-EC
Volume 68 / 67 / 70
(pb0.0001)
62 / 57 / 66
(p=0.0008)
69 / 67 / 70
(pb0.0001)
Grade 73 / 71 / 75
(pb0.0001)
72 / 69 / 74
(pb0.0001)
77 / 77 / 78
(pb0.0001)
Volume+Grade 73 / 71 / 75
(pb0.0001)
73 / 70 / 75
(pb0.0001)
77 / 77 / 77
(pb0.0001)
pMCI vs. sMCI HC EC HC-EC
Volume 62 / 61 / 63
(p=0.0007)
59 / 59 / 59
(p=0.018)
63 / 63 / 64
(p=0.0003)
Grade 71 / 70 / 71
(pb0.0001)
66 / 62 / 68
(pb0.0001)
70 / 69 / 71
(pb0.0001)
Volume+Grade 71 / 70 / 72
(pb0.0001)
65 / 60 / 68
(pb0.0001)
70 / 71 / 69
(pb0.0001)
Table 4
Classiﬁcation accuracy obtained for AD vs. pMCI and sMCI vs. CN. Results were obtained
using linear discriminant analysis through a leave-one-out cross-validation procedure.
The presented results are the classiﬁcation accuracy (acc) in %, the sensitivity (sen) in
%, the speciﬁcity (spe) in % and the p-value of the McNemar test to assess the perfor-
mance of classiﬁcation compared to random classiﬁcation. For each comparison the
best result is in bold and underline.
AD vs. pMCI HC
acc% / sen%/ spe%
(p)
EC
acc% / sen%/ spe%
(p)
HC-EC
acc% / sen%/ spe%
(p)
Volume 56 / 51 / 59
(p=0.163)
51 / 48 / 54
(p=0.852)
55 / 51 / 58
(p=0.243)
Grade 58 / 57 / 60
(p=0.032)
62 / 63 / 60
(p=0.002)
60 / 60 / 59
(p=0.012)
Volume+Grade 58 / 57 / 59
(p=0.039)
61 / 63 / 59
(p=0.004)
60 / 61 / 59
(p=0.008)
sMCI vs. CN HC EC HC-EC
Volume 63 / 65 / 62
(pb0.0001)
60 / 65 / 55
(p=0.003)
64 / 65 / 63
(pb0.0001)
Grade 69 / 74 / 63
(pb0.0001)
63 / 68 / 58
(pb0.0001)
68 / 76 / 60
(pb0.0001)
Volume+Grade 69 / 76 / 62
(pb0.0001)
64 / 72 / 55
(pb0.0001)
69 / 76 / 63
(pb0.0001)
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method based on SNIPE to study anatomical differences between AD
and CN in the entire brain (Coupe et al., 2012b). Instead of comparing
tissue probability as done in voxel-based morphometry, PBM com-
pares grading maps. Therefore the comparison between populations
is based on the score assigned to a voxel according to the similarity
of its surrounding patch with the patch libraries derived from both
populations. Here, we propose a similar approach but for studying
the typical spatial distribution of grade for each population over the
entire ADNI database. First, the grading maps were warped to our
population-speciﬁc template derived from the ADNI database and
constructed using the algorithm published in Fonov et al. (2011)
with ANIMAL non-linear registration (Collins and Evans, 1997). To
do that, each subject's T1w MRI was nonlinearly registered onto our
template. The resulting transformation was then applied to the
subject's grading maps. Finally, a mean grading map was estimated,Table 3
Comparison of the classiﬁcation performance of the different SNIPE-based biomarkers.
A McNemar test was used to compare the classiﬁcation accuracy of EC-based and
HC-based biomarkers, and to compare the grading-based and volume-based bio-









AD vs. CN p=0.0004 p=0.0250 pb0.0001 pb0.0001
pMCI vs. CN p=0.0312 p=0.0081 pb0.0001 p=0.0004
AD vs. sMCI p=0.0274 p=0.6135 p=0.0360 p=0.0003
pMCI vs. sMCI p=0.2685 p=0.0648 p=0.0019 p=0.0221voxel-by-voxel, for each population using the nonlinearly warped
maps. This way, the spatial distribution of grading values was
obtained for each population studied to enable a compact visualiza-
tion of population differences.
Fig. 6 shows the mean grading maps obtained for CN, sMCI, pMCI,
and AD populations. A clear difference can be observed between each
of the populations, especially at the HC level. At the global level, the
PBM results indicate that the posterior part of the HC seems to be
the location of major differences between sMCI and pMCI while the
main difference detected between AD and CN seems to be observed
at the body and head level of the HC (i.e., anterior part). In addition,
the right HC seems to be more discriminant between CN and sMCI,
while the left HC shows a greater difference between pMCI and AD.
This might indicate that the right HC is ﬁrst impacted by AD pathology.
4. Discussion
In this study, we showed that SNIPE-based grading biomarkers pro-
vided competitive results for early detection of AD compared with con-
ventional methods such as HC volume, CTH, and method based on TBM
features. We also found that new patch-based paradigms (nonlocal
redundancy and local sparsity) are promising ways of detecting subtle
anatomical changes between populations. Further investigations into










• HC Volume 83 / 80 / 85 78 / 77 / 78 66 / 65 / 67
• HC Grade 90 / 86 / 93 87 / 83 / 90 74 / 73 / 74
• HC-EC Volume 80 / 80 / 81 78 / 78 / 77 67 / 66 / 68
• HC-EC Grade 91 / 87 / 94 88 / 83 / 91 73 / 72 / 74
Multi-Method (Wolz et al., 2011b)
• HC Volume 81 / 81 / 79 76 / 77 / 76 65 / 63 / 67
• Manifold-based learning 85 / 87 / 83 78 / 81 / 75 65 / 64 / 66
• Cortical thickness 81 / 89 / 71 77 / 85 / 65 56 / 63 / 45
• Tensor-based method 87 / 90 / 84 79 / 82 / 76 64 / 65 / 62
• All 89 / 93 / 85 84 / 86 / 82 68 / 67 / 69
Table 6
Comparison of classiﬁcation results between SNIPE and methods studied in Liu et al.
(2012). Results shown are the best results obtained using 10-fold CV. The presented
results are the classiﬁcation accuracy in %, the sensitivity in % and the speciﬁcity in %.
Best result for each comparison is in bold and underline.










• HC Volume 83 / 80 / 86 80 / 79 / 80 66 / 67 / 65
• HC Grade 90 / 85 / 94 87 / 85 / 89 71 / 70 / 71
• HC-EC Volume 83 / 82 / 84 80 / 78 / 81 68 / 64 / 71
• HC-EC Grade 90 / 85 / 94 87 / 83 / 90 73 / 68 / 76
Sparse Classiﬁcation (Liu et al., 2012)
• COMPARE 81 / 79 / 83 – –
• Global SVM 85 / 73 / 95 81 / 73 / 90 –
• Global SRC 88 / 81 / 94 85 / 83 / 87 –
• Patch-based SVM 86 / 75 / 94 82 / 74 / 91 –
• Patch-based SRC 91 / 86 / 95 88 / 85 / 90 –
150 P. Coupé et al. / NeuroImage: Clinical 1 (2012) 141–152for future study. First, the scale of analysis needs intensive study (i.e., key
structures vs. whole brain). In future work, we hope to analyze the grad-
ing of thewhole GM area in order to shed some light on this point. In ad-
dition, the optimal way of comparing patches (i.e., redundancy vs.
sparsity) should be more carefully studied by using a similar framework
for training library construction (i.e., local vs. nonlocal). In recent
denoising literature (Mairal et al., 2009; Manjon et al., 2012), sparsity-
based ﬁlters seem to provide slightly better results than nonlocal
means ﬁlters. We believe that a nonlocal sparsity approach may be a
promising way of achieving this type of scoring, as the well-deﬁned
one-to-many correspondence would be coupled with the efﬁciency of
a sparse-based approach.
We also discussed the issue of the cross-validation procedure,
highlighting that LOOCV is a good option because the published results
can be compared without any variation due to the random splitting ofFig. 6.Mean grading map for each population overlaid on our population-speciﬁc template d
by ﬁrst nonlinearly registering all the grading maps of the ADNI database to our population-
ulation. The grading values are displayed with the same range [−0.15, 0.15] for the four pop
displayed in black.populations. Our experiment showed that, for the ADNI database,
LOOCV provided an estimate similar to the mean/median of the com-
pared CV. Therefore; we used an LOOCV procedure for the comparison
of SNIPE-based biomarkers. The discussion on bias during validation
complements our recent discussion on double-dipping issues presented
in Eskildsen et al. (in press). Both the variation in success rates due to CV
and the overestimation of success rates rate due to double-dipping
should be considered in future studies in order to limit their impact on
published results.
The comparison of SNIPE-based biomarkers in the context of early de-
tection demonstrated the high potential of the proposed framework for
this key clinical problem. Although the prediction rate obtained (71%
with LOOCV, 73% with 10-fold CV and 74% with 100× LNOCV) is not yet
suitable for clinical use, the recent progress of MRI-based biomarkers on
this challenging classiﬁcation problem is encouraging. In fact, still very re-
cently, the highest success rate was only around 56% on the ADNI data-
base (Davatzikos et al., 2011) using advanced VBM-like analysis such as
Spatial Pattern of Abnormalities for Recognition of Early AD (SPARSE-AD)
(Misra et al., 2009). It is also encouraging to note that the improvements
brought by SNIPEwere not obtained at the expense ofmethod or compu-
tational complexity. SNIPE requires only linear registration and can be
implemented easily. In addition, its computational time is around 5 mi-
nutes per subject using CPU implementation, and this time can be further
reducedbyusingGPU implementations, as alreadyproposed for real-time
processing in denoising literature (Palhano Xavier de Fontes et al., 2011).
In the case where the computational cost is not a limiting factor, variants
of SNIPE based on nonlinear registrationmight be used by involving local
or semi-local label fusion methods (Sabuncu et al., 2010; Wang et al.,
2011) after nonlinear registration of all the subjects. This would result
in a method similar to the sparse-based method (Liu et al., 2012) men-
tioned in this paper. The combination of nonlocal patch-based method
with nonlinear registration has been recently proposed for segmentation
(Fonov et al., 2012). Finally, the simplicity of the SNIPE framework results
in a robust pipeline; the processing failure rate was less than 1.7% at theerived from the subset of the ADNI database. These mean grading maps were obtained
speciﬁc template. Then, the warped grading maps were averaged according to the pop-
ulations. The values above 0.15 are set display in white and the values under−0.15 are
151P. Coupé et al. / NeuroImage: Clinical 1 (2012) 141–152linear registration step—a much lower failure rate in great contrast to the
13% obtained for the CTH method presented in Wolz et al. (2011b).
The last part of this study was dedicated to the analysis of pathology
progression using patch-based morphometry (PBM) (Coupe et al.,
2012b). With this new approach, we were able to present the mean
grading map for each population. Global PBM results seem to indicate
that the anterior part of the HC (i.e., head and anterior body) is the
more discriminant area between AD and CN populations. More interest-
ingly, the ﬁrst alterations of the HC seem to be located in the posterior
part (i.e., tail and posterior body). In further work, our PBM results
should be analyzed using HC subﬁelds atlas as already done in literature
using HC shape analysis (Apostolova et al., 2006; Frisoni et al., 2008;
Gerardin et al., 2009) or volumetric approaches (Atienza et al., 2011;
Hanseeuw et al., 2011; Mueller et al., 2010). This type of HC subﬁelds
analysis should enable a comparison of our ﬁndings with current knowl-
edge about AD progression derived from histological studies (Lace et al.,
2009; Schonheit et al., 2004).5. Conclusion
This study analyzed the capability of SNIPE to performearly detection
of AD. The experiments were carried out on the entire ADNI database
(834 subjects). A comparisonwith recentmethods proposed for the cru-
cial problemof ADprediction highlights the competitive results obtained
by SNIPE-based biomarkers. In addition, the ﬁrst results of patch-based
morphometry analysis were presented as a newway of studying pathol-
ogy progression. Finally, a discussion was provided on the promising
results proposed by new patch-based frameworks based on redundancy
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